Both in Pharmaceuticals
BridgeBio Pharma vs Insmed
Over the past year BBIO returned +26.9% and INSM returned −39.8%; their daily moves had a correlation of 0.24.
BBIO +26.9% INSM −39.8%Growth of $1, one year, split-adjusted
| Metric | BBIO | INSM |
|---|---|---|
| Price | $77.89 | $110.00 |
| Market cap | $15.17B | $24.13B |
| Today | +5.21% | +5.32% |
| 1 month | +16.3% | +4.5% |
| 6 months | +14.4% | −19.8% |
| Year to date | +1.8% | −36.8% |
| 1 year | +25.7% | −40.9% |
| Revenue growth (YoY) | +192.6% | +268.4% |
| Gross margin | 94.2% | 85.1% |
| Net margin | −23.5% | −19.1% |
| P/E (TTM) | — | — |
| Price / sales | 16.0× | 15.9× |
| Net cash | -$938.6M | $569.9M |
| Dividend yield | — | — |
| Volatility (60d) | 34.1% | 48.6% |
| Short % of float | 12.5% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).